ERICA predicts response to tamoxifen in elderly women with breast cancer
- PMID: 1759765
- PMCID: PMC2499444
ERICA predicts response to tamoxifen in elderly women with breast cancer
Abstract
Oestrogen receptor status has been determined by an immunocytochemical assay using fine-needle aspiration samples of primary breast cancers in elderly patients. In a prospective study 56 patients were treated with tamoxifen only. Satisfactory assays were achieved in 49 patients. Disease was controlled by tamoxifen in 32 of 35 (91%) patients with oestrogen receptor positive tumours, compared with only 1 (7%) of 14 who were receptor negative. Immunocytochemical assay on fine-needle aspiration samples is relatively non-invasive and simple to perform, it accurately predicts response to tamoxifen in elderly patients and can be used to select patients for tamoxifen only therapy.
Similar articles
-
Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.Anticancer Res. 1995 Mar-Apr;15(2):521-6. Anticancer Res. 1995. PMID: 7763033
-
Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients.Clin Cancer Res. 2000 Feb;6(2):616-21. Clin Cancer Res. 2000. PMID: 10690547
-
[The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].Ned Tijdschr Geneeskd. 1998 Aug 1;142(31):1772-8. Ned Tijdschr Geneeskd. 1998. PMID: 9856143 Dutch.
-
Reliability of estrogen receptors in predicting response to antiestrogens.Oncology (Williston Park). 1997 May;11(5 Suppl 4):14-8. Oncology (Williston Park). 1997. PMID: 9165501 Review.
-
[Adjuvant tamoxifen in breast cancers with negative estrogen receptors. Complete review of the literature].Bull Cancer. 1992;79(3):297-9. Bull Cancer. 1992. PMID: 1392169 Review. French. No abstract available.
Cited by
-
The differing predictive values of oestrogen receptor assays for large breast cancers.Postgrad Med J. 1992 Nov;68(805):900-3. doi: 10.1136/pgmj.68.805.900. Postgrad Med J. 1992. PMID: 1494511 Free PMC article.
-
pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients.Br J Cancer. 1996 Oct;74(7):1120-5. doi: 10.1038/bjc.1996.500. Br J Cancer. 1996. PMID: 8855985 Free PMC article.
-
Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription-polymerase chain reaction.Br J Cancer. 1995 Dec;72(6):1427-34. doi: 10.1038/bjc.1995.525. Br J Cancer. 1995. PMID: 8519655 Free PMC article.
-
Treating elderly patients with breast cancer.BMJ. 1992 May 23;304(6838):1377. doi: 10.1136/bmj.304.6838.1377. BMJ. 1992. PMID: 1611344 Free PMC article. No abstract available.
-
Determining factors which predict response to primary medical therapy in breast cancer using a single fine needle aspirate with immunocytochemical staining and flow cytometry.Virchows Arch. 1995;426(2):155-61. doi: 10.1007/BF00192637. Virchows Arch. 1995. PMID: 7757286
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical